Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,779.00p
   
  • Change Today:
    -3.00p
  • 52 Week High: 2,340.00p
  • 52 Week Low: 1,740.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 251,202
  • Market Cap: £3,947.36m
  • RiskGrade: 125
  • Beta: 0.01

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Cynthia Schwalm
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,779.00p
Change Today -3.00p
% Change -0.17 %
52 Week High 2,340.00p
52 Week Low 1,740.00p
Volume 251,202
Shares Issued 221.89m
Market Cap £3,947.36m
Beta 0.01
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.63% below the market average73.63% below the market average73.63% below the market average73.63% below the market average73.63% below the market average
16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average
Price Trend
52.69% below the market average52.69% below the market average52.69% below the market average52.69% below the market average52.69% below the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Income
40.03% above the market average40.03% above the market average40.03% above the market average40.03% above the market average40.03% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.00% above the market average42.00% above the market average42.00% above the market average42.00% above the market average42.00% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 14-Aug-25 20-Mar-25
Paid 18-Sep-25 01-May-25
Amount 36.00¢ 48.00¢

Trades for 12-Aug-2025

Time Volume / Share Price
15:53 84 @ 1,779.00p
15:53 83 @ 1,779.00p
15:53 48 @ 1,779.00p
15:53 50 @ 1,779.00p
15:53 288 @ 1,779.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page